Fresenius Medical Care stock sits 14.03 percent below its EUR 47.54 52-week high
Published on 10/26/2026 at 17:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPrice position and reporting date
- The 52-week high of EUR 47.54 leaves the stock 14.03 percent below that level on October 26, 2026.
- Fresenius Medical Care carries a EUR 10.9 billion market capitalization and a price-to-earnings ratio of 12.32.
- Fresenius Medical Care stock costs EUR 40.87 at Lang & Schwarz on October 26, 2026 at 5:04 p.m. CEST, 1.01 percent above the Xetra close of October 23, 2026.
- Third-quarter reporting is scheduled for November 3, 2026.
Fresenius Medical Care stock (ISIN DE0005785802) sits 14.03 percent below its 52-week high of EUR 47.54 on October 26, 2026. The comparison places the dialysis specialist below its yearly peak while the next financial reporting date approaches. At Lang & Schwarz, the stock was trading at EUR 40.87 on October 26, 2026 at 5:04 p.m. CEST, up 1.01 percent versus the Xetra close of October 23, 2026 at EUR 40.46.
The yearly range leaves room
The current quote is EUR 6.67 below the 52-week high and EUR 6.30 above the 52-week low of EUR 34.57. That span gives investors a clear measure of the stock's position: the price is closer to the middle of the range than to either extreme, despite the positive daily move.
Fresenius Medical Care's market capitalization stood at EUR 10.9 billion on October 26, 2026. Its price-to-earnings ratio was 12.32, while trading volume reached 254,143 shares by the latest October 26 market snapshot.
November 3 marks the next date
The company lists November 3, 2026 as the date for its third-quarter 2026 reporting. The investor calendar also separates the financial results release from the quarterly financial report listed for November 6, 2026, giving investors two dates for the reporting sequence, according to Fresenius Medical Care.
The company operates dialysis clinics and supplies related medical products, including dialysis machines, dialyzers and treatment solutions. Its business combines care services with product manufacturing, so the upcoming report can put the valuation figures into an operating context.
What the price position says
The stock's 14.03 percent distance from the 52-week high is the central chart measure for investors today. The EUR 10.9 billion market value and 12.32 price-to-earnings ratio provide a second lens, while the November reporting date supplies the next fixed point for assessing new company figures.
Trading stays above the Xetra close
Fresenius Medical Care stock was trading at EUR 40.87 at Lang & Schwarz on October 26, 2026 at 5:04 p.m. CEST, 1.01 percent above the Xetra close of October 23, 2026 at EUR 40.46.
The further course of trading is shown by the continuously updated real-time quote of Fresenius Medical Care stock.
Fresenius Medical Care stock facts
- Company: Fresenius Medical Care AG & Co. KGaA
- ISIN: DE0005785802
- Ticker: FME
- Primary exchange: Xetra
- Price Lang & Schwarz (as of October 26, 2026, 5:04 p.m. CEST): EUR 40.87
- Change versus Xetra close: plus 1.01 percent
- Xetra close (October 23, 2026): EUR 40.46
- Market capitalization: EUR 10.9 billion (as of October 26, 2026)
- 52-week range: EUR 34.57-EUR 47.54 (as of October 26, 2026)
- Sector / Industry: Healthcare / Medical - Care Facilities
- Price-to-earnings ratio: 12.32 (as of October 26, 2026)
Market context: Market report DAX.
